XBiotech Inc.

NASDAQ:XBIT

Biotechnology

Healthcare
$1.73 -0.84%

-$0.02 today

Market cap
$52.74M
Beta
0.84
P/E (TTM)
-1.8
EPS (TTM)
-$1.32
52W Low $2.09High $3.61

Volume 0.06M

Average 0.03M

XBIT Deferred Income Tax

The difference between tax expense recognized and tax actually paid in cash during the period.

XBiotech Inc.NASDAQ: XBIT

Deferred Income Tax · Q1 FY2026 · quarter ended Mar 2026

Deferred income tax outflow grows to $0

Q1 FY2026 deferred income tax was $0, compared with $0 a year earlier. Trailing-twelve-month deferred income tax was $5K.

Context

  • Deferred income tax increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly deferred income tax holds near $0 or moves back toward the trailing-twelve-month quarterly average of $1.25K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0-100.0% QoQ
Last fiscal yearDec 2025
$5K— YoY
LTMMar 2026
$5K— YoY
Deferred Income Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Deferred Income Tax history

USD · from the cash flow

Latest · FY2025
5K USD
Year-over-year change
—

Deferred Income Tax vs competitors

How XBIT compares with its peers on the latest reported figures

  • XBIT's LTM Mar 2026 deferred income tax of $5K is the largest of the 9 companies compared; the peer median is $0.
XBIT Competitors Peer median
Deferred Income Tax for XBIT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
XBITXBiotech Inc.LTM Mar 2026$5K ———
RLMDRelmada Therapeutics, Inc.LTM Mar 2026$0 ———
NTRBNutriband Inc.LTM Apr 2026$0 ——0.0%
ADAGAdagene Inc.LTM Jun 2024$0 ——0.0%
FBIOFortress Biotech, Inc.LTM Mar 2026$0 ——0.0%
ACRVAcrivon Therapeutics, Inc. Common StockLTM Mar 2026$0 ———
GANXGain Therapeutics, Inc.LTM Mar 2026$0 ———
ACETAdicet Bio, Inc.LTM Mar 2026$0 ———
TCRXTScan Therapeutics, Inc.LTM Mar 2026$0 ——0.0%
Peer median (excluding XBIT) $0——0.0%

Competitors are the stored peer set for XBIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(17.41M)(32.9M)(24.56M)(38.53M)(45.54M)
Depreciation & Amortization2.65M2.61M1.74M1.75M1.69M
Deferred Income Tax00005K
Stock-Based Compensation4.46M5.06M3.26M1.75M3.62M
Change in Working Capital79.75M7.6M2.72M(1.46M)3.64M
Accounts Receivables1.73M7.34M829K77K574K
Inventory00000
Accounts Payables(514K)357K91K(364K)(688K)
Other Working Capital78.53M(97K)1.8M(1.17M)3.75M
Other Non-Cash Items4.46M2.8M(1.89M)5.53M(3.33M)
Operating Cash Flow69.45M(14.82M)(18.73M)(30.96M)(39.92M)
Capital Expenditures(3.53M)(585K)(362K)(1.3M)(289K)
Acquisitions (Net)00000
Purchases of Investments0(63.31M)000
Sales of Investments00000
Other Investing Activities0061.86M00
Investing Cash Flow(3.53M)(63.89M)61.5M(1.3M)(289K)
Debt Repayment00010.25M(10.25M)
Common Stock Issued005K00
Common Stock Repurchased00000
Dividends Paid(75M)0000
Other Financing Activities8M0(14K)200K0
Financing Cash Flow(67.01M)0(9K)10.45M(10.25M)
Effect of Forex Changes705K(961K)(46K)(5.53M)3.33M
Net Change in Cash(383K)(79.68M)42.72M(27.35M)(47.13M)
Free Cash Flow65.92M(15.41M)(19.09M)(32.27M)(40.21M)

XBiotech Inc.

NASDAQ:XBIT

Intrinsic Alpha fair value

Locked

Current Price

$1.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.